CWM
ABBV icon

Cornerstone Wealth Management’s AbbVie ABBV Stock Holding History

Cornerstone Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Sell
14,618
-486
-3% -$105K 0.16% 135
2026
Q1 		$3.28M Buy
15,104
+1,493
+11% +$331K 0.16% 131
2025
Q4 		$3.11M Buy
13,611
+78
+0.6% +$17.8K 0.16% 135
2025
Q3 		$3.13M Buy
13,533
+629
+5% +$128K 0.17% 123
2025
Q2 		$2.4M Buy
12,904
+72
+0.6% +$13.4K 0.15% 135
2025
Q1 		$2.69M Sell
12,832
-182
-1% -$35.4K 0.18% 116
2024
Q4 		$2.31M Buy
13,014
+316
+2% +$58.1K 0.16% 132
2024
Q3 		$2.51M Sell
12,698
-212
-2% -$39.6K 0.18% 116
2024
Q2 		$2.21M Sell
12,910
-217
-2% -$35.9K 0.17% 122
2024
Q1 		$2.39M Sell
13,127
-715
-5% -$123K 0.19% 114
2023
Q4 		$2.15M Sell
13,842
-2,890
-17% -$421K 0.18% 119
2023
Q3 		$2.49M Sell
16,732
-119
-0.7% -$17.5K 0.24% 103
2023
Q2 		$2.27M Buy
16,851
+1,677
+11% +$246K 0.2% 112
2023
Q1 		$2.42M Buy
+15,174
New +$2.32M 0.24% 99
2022
Q3 		$2.29M Buy
17,082
+519
+3% +$74.5K 0.26% 90
2022
Q2 		$2.54M Sell
16,563
-17,046
-51% -$2.6M 0.28% 78
2022
Q1 		$5.45M Buy
33,609
+437
+1% +$63.5K 0.53% 41
2021
Q4 		$4.5M Buy
33,172
+2,418
+8% +$286K 0.43% 50
2021
Q3 		$3.32M Buy
30,754
+1,954
+7% +$223K 0.35% 66
2021
Q2 		$3.24M Buy
28,800
+1,745
+6% +$197K 0.34% 68
2021
Q1 		$2.93M Buy
27,055
+859
+3% +$91.9K 0.35% 65
2020
Q4 		$2.81M Buy
26,196
+1,154
+5% +$111K 0.35% 60
2020
Q3 		$2.19M Buy
25,042
+346
+1% +$32.6K 0.33% 63
2020
Q2 		$2.42M Buy
24,696
+146
+0.6% +$12.9K 0.39% 50
2020
Q1 		$1.87M Buy
24,550
+547
+2% +$46.6K 0.36% 53
2019
Q4 		$2.13M Buy
24,003
+9,796
+69% +$813K 0.34% 59
2019
Q3 		$1.08M Buy
14,207
+8,002
+129% +$549K 0.19% 113
2019
Q2 		$453K Buy
6,205
+729
+13% +$57.3K 0.08% 222
2019
Q1 		$1.16M Buy
5,476
+49
+0.9% +$4.01K 0.14% 168
2018
Q4 		$499K Sell
5,427
-1,156,131
-100% -$102M 0.11% 192
2018
Q3 		$12.8M Buy
1,161,558
+59,375
+5% +$5.63M 0.16% 141
2018
Q2 		$11.8M Buy
1,102,183
+1,089,763
+8,774% +$106M 0.13% 166
2018
Q1 		$1.13M Buy
12,420
+79
+0.6% +$8.68K 0.22% 98
2017
Q4 		$1.22M Sell
12,341
-454
-4% -$42.8K 0.23% 97
2017
Q3 		$1.16M Buy
12,795
+1,604
+14% +$122K 0.24% 93
2017
Q2 		$800K Buy
11,191
+1,636
+17% +$110K 0.18% 121
2017
Q1 		$622K Buy
9,555
+1,687
+21% +$106K 0.15% 134
2016
Q4 		$490K Buy
7,868
+660
+9% +$40.3K 0.16% 133
2016
Q3 		$455K Buy
+7,208
New +$467K 0.17% 126

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Cornerstone Wealth Management's ABBV Position: Q2 2026 in Review

Cornerstone Wealth Management reduced its AbbVie (ABBV) stake by 3.2% in Q2 2026, selling an estimated $105K and leaving 14,618 shares worth $3.68M. The position accounts for 0.16% of the portfolio, ranked #135.

Cornerstone Wealth Management first reported a position in ABBV in Q3 2016 and has held it in 39 quarters since. The position peaked at $12.8M in Q3 2018. 1,256 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cornerstone Wealth Management held 14,618 shares of AbbVie worth $3.68M as of Q2 2026.
  • Cornerstone Wealth Management sold 486 AbbVie shares in Q2 2026, an estimated $105K.
  • AbbVie made up 0.16% of Cornerstone Wealth Management's portfolio in Q2 2026, its #135 holding.
  • Cornerstone Wealth Management first reported a position in AbbVie in Q3 2016 and has held it in 39 quarters since.
  • Cornerstone Wealth Management's AbbVie position peaked at $12.8M in Q3 2018.
  • 1,256 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.